Daniel van den Bergh
Investor, Board Director at SureCo
United States
Daniel van den Bergh, Investor, Board Director at SureCo is an active investor based in United States. This profile covers what Daniel van den Bergh backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCCorporate VC
- Stages
- Series B
- Invests in
- Healthcare & BiotechDigital Health & HealthTechMedTech & Medical DevicesSaaS & Enterprise
- Location
- United States
- Typical check
- $3M
- Past investments
- 64
Notable investments
iRhythm TechnologiesArcxis BiotechnologiesKit Check
IntelyCare
NOCD
Astute Medical
HemosphereNuPathe
Proteus Digital HealthTriVascular
NordicXanitosHow to reach Daniel van den Bergh
Angels and operators like Daniel van den Bergh reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Daniel van den Bergh
Frequently Asked Questions
What does Daniel van den Bergh invest in?
Daniel van den Bergh invests in Healthcare & Biotech, Digital Health & HealthTech, MedTech & Medical Devices and SaaS & Enterprise, typically at Series B. Match your sector and stage, then reach out with a personalized pitch.
What stage does Daniel van den Bergh invest at?
Daniel van den Bergh typically invests at Series B. Lead with traction that fits the stage when you reach out.
What is Daniel van den Bergh's typical check size?
Daniel van den Bergh typically writes checks around $3M. Use it as a signal for whether your raise fits their stage.
How do I contact Daniel van den Bergh?
Unlock Daniel van den Bergh's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.